Editorial
doi: 10.1111/bjd.17777.
Novel therapeutic approach with PAC-14028 cream, a TRPV1 antagonist, for patients with mild-to-moderate atopic dermatitis
Affiliations
- PMID: 31025744
- DOI: 10.1111/bjd.17777
Item in Clipboard
Editorial
Novel therapeutic approach with PAC-14028 cream, a TRPV1 antagonist, for patients with mild-to-moderate atopic dermatitis
Br J Dermatol.
2019 May.
No abstract available
Comment on
-
Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.Br J Dermatol. 2019 May;180(5):1030-1038. doi: 10.1111/bjd.17455. Epub 2019 Jan 8. Br J Dermatol. 2019. PMID: 30623408 Free PMC article. Clinical Trial.
Similar articles
-
Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.Br J Dermatol. 2019 May;180(5):1030-1038. doi: 10.1111/bjd.17455. Epub 2019 Jan 8. Br J Dermatol. 2019. PMID: 30623408 Free PMC article. Clinical Trial.
-
Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases.Arch Pharm Res. 2012 Mar;35(3):393-6. doi: 10.1007/s12272-012-0321-6. Arch Pharm Res. 2012. PMID: 22477184
-
A TRPV1 antagonist, PAC-14028 does not increase the risk of tumorigenesis in chemically induced mouse skin carcinogenesis.Regul Toxicol Pharmacol. 2020 Apr;112:104613. doi: 10.1016/j.yrtph.2020.104613. Epub 2020 Feb 7. Regul Toxicol Pharmacol. 2020. PMID: 32044384
-
Novel topical and systemic therapies in atopic dermatitis.Immunol Med. 2019 Jun;42(2):84-93. doi: 10.1080/25785826.2019.1642727. Epub 2019 Jul 18. Immunol Med. 2019. PMID: 31318324 Review.
-
Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.Hong Kong Med J. 2015 Oct;21(5):417-25. doi: 10.12809/hkmj144472. Epub 2015 Aug 28. Hong Kong Med J. 2015. PMID: 26314567 Review.
Cited by
-
The Role of TRP Channels in Sepsis and Colitis.Int J Mol Sci. 2024 Apr 27;25(9):4784. doi: 10.3390/ijms25094784. Int J Mol Sci. 2024. PMID: 38731999 Free PMC article. Review.
-
New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature.J Clin Med. 2022 Aug 24;11(17):4974. doi: 10.3390/jcm11174974. J Clin Med. 2022. PMID: 36078904 Free PMC article. Review.
-
TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases.Signal Transduct Target Ther. 2023 Jul 5;8(1):261. doi: 10.1038/s41392-023-01464-x. Signal Transduct Target Ther. 2023. PMID: 37402746 Free PMC article. Review.
-
Bifidobacterium longum subsp. longum BG-L47 boosts growth and activity of Limosilactobacillus reuteri DSM 17938 and its extracellular membrane vesicles.Appl Environ Microbiol. 2024 Jul 24;90(7):e0024724. doi: 10.1128/aem.00247-24. Epub 2024 Jun 18. Appl Environ Microbiol. 2024. PMID: 38888338 Free PMC article.
-
A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability.Sci Rep. 2021 Jan 8;11(1):246. doi: 10.1038/s41598-020-80725-z. Sci Rep. 2021. PMID: 33420359 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
